Amy E. Veroff
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Dementia and Cognitive Impairment Research 8
- Attention Deficit Hyperactivity Disorder 3
- Schizophrenia research and treatment 2
-
- Functional Brain Connectivity Studies 4
- Co-authors
- Neal R. Cutler (11 shared papers)Albert Enz (1 shared paper)René Spiegel (1 shared paper)Ezio Giacobini (1 shared paper)John J. Sramek (8 shared papers)Ellen Grober (3 shared papers)Godfrey D. Pearlson (3 shared papers)Richard B. Lipton (2 shared papers)
- Journals
- Alzheimer s & Dementia (3 papers)Alzheimer Disease & Associated Disorders (2 papers)Annals of Pharmacotherapy (2 papers)British Journal of Clinical Pharmacology (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Amy E. Veroff
23 papers receiving 648 citations
Peers
Comparison fields: 5 of 81
- Psychiatry and Mental health 201
- Pharmacology 211
- Cognitive Neuroscience 154
- Biological Psychiatry 14
- Neurology 42
Countries citing papers authored by Amy E. Veroff
This map shows the geographic impact of Amy E. Veroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Veroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Veroff more than expected).
Fields of papers citing papers by Amy E. Veroff
This network shows the impact of papers produced by Amy E. Veroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Veroff. The network helps show where Amy E. Veroff may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Veroff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 197 | |
| 2 | 1984 | 77 | |
| 3 | 1998 | 50 | |
| 4 | 1980 | 49 | |
| 5 | 1995 | 41 | |
| 6 | 2018 | 39 | |
| 7 | 1991 | 37 | |
| 8 | 1978 | 30 | |
| 9 | 1993 | 24 | |
| 10 | 2022 | 21 | |
| 11 | 1975 | 19 | |
| 12 | 1993 | 17 | |
| 13 | Alzheimer's Disease: Optimizing Drug Development Strategies | 1994 | 16 |
| 14 | 2001 | 13 | |
| 15 | 1995 | 12 | |
| 16 | 2000 | 10 | |
| 17 | 1982 | 8 | |
| 18 | 1996 | 4 | |
| 19 | 1996 | 4 | |
| 20 | 1982 | 2 |
About Amy E. Veroff
Amy E. Veroff is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience, Pharmacology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 673 indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (8 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Functional Brain Connectivity Studies (4 papers), Attention Deficit Hyperactivity Disorder (3 papers), Alzheimer's disease research and treatments (2 papers), Computational Drug Discovery Methods (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Schizophrenia research and treatment (2 papers). The work is most often cited by research in Psychiatry and Mental health (201 citations), Pharmacology (211 citations), Cognitive Neuroscience (154 citations), Biological Psychiatry (14 citations) and Neurology (42 citations). Amy E. Veroff has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Neal R. Cutler, Albert Enz, René Spiegel, Ezio Giacobini, John J. Sramek, Ellen Grober, Godfrey D. Pearlson, Richard B. Lipton, John J. Sramek and J. Raymond DePaulo. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer Disease & Associated Disorders, Annals of Pharmacotherapy, British Journal of Clinical Pharmacology and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.